Cancer Research AACR Conference on Molecular Diagnostics - 2008  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 29, 2206-2211, December 1, 1969]
© 1969 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Butler, W. H.
Right arrow Articles by Lijinsky, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Butler, W. H.
Right arrow Articles by Lijinsky, W.

Carcinogenesis in Rats by Aflatoxins B1, G1, and B21

W. H. Butler2, M. Greenblatt3 and W. Lijinsky3, 4,

Division of Oncology, Institute for Medical Research, The Chicago Medical School, Chicago, Illinois 60012, Toxicology Research Unit, Medical Research Council, Carshalton, Surrey, England, and Eppley Institute for Research in Cancer, University of Nebraska, College of Medicine, Omaha, Nebraska 68105

Aflatoxins B1, G1, and B2 of high purity have been prepared from a crude mixture of aflatoxins and have been tested by long-term feeding in drinking water to rats, at concentrations of 1 µg/ml and 3 µg/ml. Aflatoxin B1 produced liver tumors in 19 of 30 rats given a total dose of 2 mg each; 3 of 10 animals receiving a total dose of 1 mg developed liver tumors. Aflatoxin G1 gave rise to liver tumors in 3 of 30 animals given a total dose of 2 mg and to 1 liver tumor in 10 animals given 1 mg each. However, of 26 rats receiving a total of 6 mg aflatoxin G1, 21 animals developed liver tumors, and 6 animals had kidney tumors. A number of animals receiving 2 mg of aflatoxin G1 also had kidney tumors. There was no sex difference in the incidence of liver tumors, but kidney tumors were seen only in males. The liver tumors were almost all hepatocellular carcinomas. No liver tumors were seen in 10 rats receiving a total dose of 1 mg aflatoxin B2.

1 Supported by USPHS Contract No. 43-65-67 and 43-68-959 from the National Cancer Institute.

2 Present address: Toxicology Research Unit, Medical Research Council Laboratories, Carshalton, Surrey, England.

3 Present address: Eppley Institute for Research in Cancer, University of Nebraska College of Medicine, Omaha, Nebraska 68105.

4 Recipient of a Research Career Development Award, USPHS.

Received 2/ 3/69. Accepted 4/24/69.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1969 by the American Association for Cancer Research.